Stockscreener 앱 받기
1.164
2.18%
-0.026
전일 마감가:
$1.19
열려 있는:
$1.18
하루 거래량:
638.52K
Relative Volume:
0.27
시가총액:
$267.18M
수익:
$8.95M
순이익/손실:
$-21.49M
주가수익비율:
-9.70
EPS:
-0.12
순현금흐름:
$-29.24M
1주 성능:
+14.12%
1개월 성능:
+23.27%
6개월 성능:
+72.19%
1년 성능:
+28.15%
1일 변동 폭
$1.15
$1.185
1주일 범위
$1.0294
$1.31
52주 변동 폭
$0.3651
$1.31
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
명칭
Lineage Cell Therapeutics Inc
전화
510-871-4188
주소
2173 Salk Avenue, Suite 200, Carlsbad, CA
LCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.17 | 292.30M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.52 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.84 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.60 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.66 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.09 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-20 | 개시 | Craig Hallum | Buy |
| 2022-11-02 | 개시 | Robert W. Baird | Outperform |
| 2022-06-14 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Noble Capital Markets | Outperform |
| 2021-03-31 | 개시 | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc 주식(LCTX)의 최신 뉴스
Published on: 2025-08-21 02:00:17 - kangso.co.kr
How to track smart money flows in Lineage Cell Therapeutics Inc.Weekly Earnings Recap & Community Verified Trade Signals - Newser
Trend Reversal Possible in Lineage Cell Therapeutics Inc. Charts IndicateAnalyst Upgrade & AI Enhanced Trade Execution Alerts - beatles.ru
Will breakout in Lineage Cell Therapeutics Inc. lead to full recoveryJuly 2025 Technicals & Accurate Intraday Trading Signals - Newser
Heatmap analysis for Lineage Cell Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - Newser
Is Lineage Cell Therapeutics Inc. stock a value trapWeekly Volume Report & Weekly Momentum Picks - thegnnews.com
Published on: 2025-08-17 09:06:42 - mustnews.co.kr
How to recover losses in Lineage Cell Therapeutics Inc. stockQuarterly Profit Summary & Safe Capital Growth Stock Tips - Newser
Combining price and volume data for Lineage Cell Therapeutics Inc.2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
What does recent volatility data suggest for Lineage Cell Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
Relative strength of Lineage Cell Therapeutics Inc. in sector analysisGDP Growth & Safe Entry Trade Reports - Newser
Applying Wyckoff theory to Lineage Cell Therapeutics Inc. stockWeekly Stock Recap & Reliable Intraday Trade Alerts - Newser
What data driven models say about Lineage Cell Therapeutics Inc.’s futureJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Lineage Cell (LCTX) Surges 25% Intraday: Algorithmic Frenzy or Retail Rally? - AInvest
Behind Lineage Cell Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
Lineage Cell Surges 24.5% on Biotech Sector Rally: What's Fueling the Momentum? - AInvest
Lineage Cell (LCTX.A) Surges 14.7% — Was It Driven by Order Flow or Sector Momentum? - AInvest
Risk adjusted return profile for Lineage Cell Therapeutics Inc. analyzedTrade Exit Report & Community Consensus Picks - Newser
Exit strategy if you’re trapped in Lineage Cell Therapeutics Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser
Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics - TipRanks
Craig-Hallum Keeps Their Buy Rating on Lineage Therap (LCTX) - The Globe and Mail
Will Lineage Cell Therapeutics Inc. Benefit From Broader Market BounceNew Guidance & Weekly High Return Opportunities - sundaytimes.kr
Detecting support and resistance levels for Lineage Cell Therapeutics Inc.July 2025 Volume & Free Community Supported Trade Ideas - Newser
How to build a dashboard for Lineage Cell Therapeutics Inc. stock2025 Price Momentum & Low Risk Entry Point Guides - Newser
Is Lineage Cell Therapeutics Inc. stock ready for a breakout2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Analyzing recovery setups for Lineage Cell Therapeutics Inc. investors2025 Market Overview & Precise Buy Zone Tips - Newser
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2025 Earnings Call Transcript - MSN
Lineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating - TipRanks
Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges - MSN
Lineage Cell: Q2 Earnings Snapshot - Stamford Advocate
Can a trend reversal in Lineage Cell Therapeutics Inc. lead to recoveryPortfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Lineage Cell Therapeutics (LCTX): Strategic Partnerships and Platform Expansion as Catalysts for Value Creation - AInvest
Lineage Cell Therapeutics Inc (LCTX) Q2 2025 Earnings Call Highlights: Strategic Partnerships ... - Yahoo Finance
A Peek at Lineage Cell Therapeutics's Future Earnings - 富途牛牛
Lineage Cell Therapeutics Inc (LCTX) Q2 2025 Earnings Call Highl - GuruFocus
Lineage Cell Therapeutics (LCTX) Reports Vision Gains and Strate - GuruFocus
Lineage Cell Therapeutics (LCTX): Navigating Pipeline Progress Amid Financial Challenges - AInvest
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Lineage Cell Revenue Doubles in Q2 - Nasdaq
Transcript : Lineage Cell Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Lineage Cell Therapeutics: Navigating Key Contradictions in Manufacturing, Trials, and FDA Communication in 2025Q2 Earnings Call - AInvest
Lineage Cell Therapeutics Q2 2025: OpRegen Progress and Diversification Strategy - AInvest
Earnings call transcript: Lineage Cell Therapeutics Q2 2025 sees revenue boost - Investing.com Nigeria
Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Lineage Cell Therapeutics reports Q2 2025 results, clinical updates, and symposium. - AInvest
Lineage Cell Therapeutics earnings missed by $0.10, revenue topped estimates - Investing.com Canada
Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c) - TipRanks
Can swing trading help recover from Lineage Cell Therapeutics Inc. lossesFree Short Term Setup With Predictive Chart - Newser
What makes Lineage Cell Therapeutics Inc. stock price move sharplyAccurate Forecast System with AI Support - Newser
Lineage Cell Therapeutics Inc (LCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lineage Cell Therapeutics Inc 주식 (LCTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Howe Jill Ann | Chief Financial Officer |
Nov 26 '24 |
Buy |
0.59 |
15,000 |
8,850 |
25,500 |
| Samuel George A. III | General Counsel |
Nov 26 '24 |
Buy |
0.60 |
15,000 |
9,000 |
22,184 |
| Mulroy Michael H. | Director |
Nov 22 '24 |
Buy |
0.57 |
40,000 |
22,640 |
298,555 |
| Culley Brian M | President and CEO |
Nov 21 '24 |
Buy |
0.60 |
40,000 |
24,000 |
194,842 |
0.95%
0.54%
자본화:
|
볼륨(24시간):